VMD vs. AGL, PNTG, AVAH, CSTL, GRAL, FLGT, AUNA, INNV, TALK, and DCGO
Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include agilon health (AGL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Grail (GRAL), Fulgent Genetics (FLGT), Auna (AUNA), InnovAge (INNV), Talkspace (TALK), and DocGo (DCGO). These companies are all part of the "healthcare" industry.
Viemed Healthcare vs.
Viemed Healthcare (NASDAQ:VMD) and agilon health (NYSE:AGL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking and institutional ownership.
74.2% of Viemed Healthcare shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 3.2% of agilon health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Viemed Healthcare has a net margin of 4.87% compared to agilon health's net margin of -6.88%. Viemed Healthcare's return on equity of 8.72% beat agilon health's return on equity.
agilon health has a consensus price target of $4.03, indicating a potential upside of 29.33%. Given agilon health's higher possible upside, analysts clearly believe agilon health is more favorable than Viemed Healthcare.
Viemed Healthcare has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, agilon health has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.
agilon health received 49 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 45.22% of users gave agilon health an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.
Viemed Healthcare has higher earnings, but lower revenue than agilon health. agilon health is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, agilon health had 9 more articles in the media than Viemed Healthcare. MarketBeat recorded 11 mentions for agilon health and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.66 beat agilon health's score of 0.31 indicating that Viemed Healthcare is being referred to more favorably in the media.
Summary
Viemed Healthcare beats agilon health on 13 of the 19 factors compared between the two stocks.
Get Viemed Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viemed Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:VMD) was last updated on 1/20/2025 by MarketBeat.com Staff
Free VMD Stock Alerts